After optimization of one of the initial hits through medicinal chemistry, one fascin inhibitor showed improved activity in blocking actin-binding and actin-bundling activities of fascin, as well as inhibiting the migration, invasion, and metastasis of tumor cells [32]. This evidence concerns the gene FSCN1 and neoplasm.